Sagimet Biosciences Inc.
Sagimet Biosciences Inc. scores highest on Nitro (72) and lowest on Price (26). Its PosiPenta is 47.34 out of 100, around the middle of similar companies.
On the Penta Grid this week, Sagimet Biosciences Inc. is Grid #328 of 837 in the Healthcare sector in United States, and Grid #2,179 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc. | 47.34 | 26 | 33 | 72 | 70 | 35 |
| Cytek Biosciences, Inc. | 58.94 | 28 | 71 | 84 | 59 | 54 |
| The Oncology Institute, Inc. | 65.20 | 0 | 68 | 92 | 99 | 68 |
| Sana Biotechnology, Inc. | 30.63 | 15 | 48 | 23 | 25 | 42 |
| Iambic Therapeutics, Inc. | 44.33 | 0 | 26 | 94 | 64 | 38 |
| OmniAb, Inc. | 55.46 | 24 | 50 | 88 | 61 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -6.32 |
| P/B ratio | 2.22 |
EEarnings
| Trailing EPS | ₹-120.29 |
| Forward EPS | ₹-123.19 |
NNitro
| Price | 759.61 |
| 52-week high | 1084.39 |
| 52-week low | 426.22 |
| Fall from 52-week high | 29.9% |
TTorque
| Return on equity (ROE) | -24.37% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 3.49 |
| Market cap | ₹5,386 Cr |
| Insider holding | 2.95% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Sagimet Biosciences Inc.'s PosiPenta score?
Sagimet Biosciences Inc.'s PosiPenta is 47.34 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Sagimet Biosciences Inc. stand on the Penta Grid?
On the Penta Grid this week, Sagimet Biosciences Inc. is Grid #328 of 837 in the Healthcare sector in United States, and Grid #2,179 of 4,000 in United States.
Which PosiPenta pillar is strongest for Sagimet Biosciences Inc.?
Nitro (momentum), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Sagimet Biosciences Inc.?
Price (valuation), with a score of 26 out of 100: weaker than most similar companies.
Has Sagimet Biosciences Inc.'s PosiPenta changed since last week?
Yes, it rose 3.31 points, from 44.03 to 47.34.
PositoAI is for research and education only and is not investment advice.